NEW YORK (GenomeWeb News) – Agilent Technologies said today that France’s Institut de cancerologie Gustave Roussy Genomic Center has renewed and expanded an agreement making it a service provider and training center for Agilent’s microarray technologies.
The company said that IGR, which became an Agilent service provider for gene expression microarrays in 2005, has renewed that status to offer “a broad panel of microarray technologies,” such as comparative genomic hybridization, one-color and dual-color gene expression, and microRNA profiling.
The new agreement gives IGR an expanded panel of services for CGH and miRNA applications, and the center also received authorization to perform training for technologies that meet Agilent’s certification standards.
Agilent gave IGR the new and extended service provider status after assessments of the center’s proficiency in analyzing Agilent’s 60-mer oligo microarrays and using the Agilent 2100 Bioanalyzer, as well as sample labeling, hybridization, array scanning, feature extraction, and data analysis.
"The partnership between IGR and Agilent is very comprehensive and efficient, ranging from Certified Service Provider, to European Training Center but also at the R&D level," Agilent Diagnostics Senior Director Michael McNulty said in a statement. "We will considerably reinforce our partnership, and are very impressed by the efficient integration of our CGH, gene expression and miRNA technologies in the innovative research programs and efforts aiming to improve knowledge that leads to more patient-specific treatments."